Drug Profile
Plasma (Octaplas LG) - Octapharma
Alternative Names: Octaplas (US) - Octapharma; Octaplas LG; OctaplasLG; Plasma (OctaplasLG) - OctapharmaLatest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator Octapharma
- Class Anti-infectives; Anti-inflammatories; Antihaemorrhagics; Blood products and substitutes
- Mechanism of Action Blood coagulation factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Blood coagulation disorders; Haemorrhage; Thrombotic thrombocytopenic purpura
- Phase II Septic shock
Most Recent Events
- 30 Mar 2021 Launched for Blood coagulation disorders (In children, In adolescents) in USA (IV)
- 30 Mar 2021 Launched for Thrombotic thrombocytopenic purpura (Therapeutic plasma exchange) (In children, In adolescents) in USA (IV)
- 29 Mar 2021 Registered for Blood coagulation disorders (In children, In adolescents) in USA (IV)